Cleerly LABS vs Viz AAA

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by Viz.ai

AI Verdict

These two tools are adjacent rather than direct competitors, as they address distinct cardiovascular pathologies. Cleerly LABS focuses on comprehensive analysis of coronary CT angiography to detect and characterize atherosclerosis and stenosis for personalized heart disease management. In contrast, Viz AAA is designed for the rapid detection and triage of suspected Abdominal Aortic Aneurysms from CT angiography scans, aiming to accelerate acute care coordination.

Choose Cleerly LABS if…

Choose Cleerly LABS if your primary goal is a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to meticulously quantify and characterize atherosclerosis and stenosis. This tool is ideal for cardiologists and radiologists focused on personalized heart disease management, tracking disease progression, and detailed risk assessment based on coronary plaque burden.

View Cleerly LABS →

Choose Viz AAA if…

Choose Viz AAA if your priority is the rapid, AI-powered detection and automated triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, particularly in emergency or high-volume settings. This solution excels at accelerating diagnosis, enabling real-time alerts, and streamlining care coordination among multidisciplinary teams for urgent vascular interventions.

View Viz AAA →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS Viz AAA
Pricing Varies Enterprise (hospital/health system)
Deployment Cloud, On-premise Cloud-based, integrates with PACS and EHR systems.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz AAA

Viz AAA emphasizes real-time alerts, mobile access to high-fidelity imaging, and a HIPAA-compliant communication platform, which streamlines acute care coordination and immediate actionability for care teams. Cleerly LABS, while offering a web-based platform with 3D visualization for detailed analysis, does not highlight the same level of immediate, collaborative workflow integration.

Clinical Value

Tie

Both tools provide significant clinical value in their respective specialties. Cleerly LABS offers comprehensive, longitudinal assessment and personalized management for chronic coronary artery disease, backed by studies showing improved diagnostic accuracy and changes in clinical management. Viz AAA excels in rapid, accurate detection and triage of acute, life-threatening abdominal aortic aneurysms, with strong sensitivity and specificity in real-world data. Their distinct applications make a direct comparison of 'more' value difficult.

Pricing & Value

Cleerly LABS

Cleerly LABS provides transparent, per-analysis pricing, including a current discount and growing insurance coverage from major payors and Medicare, which allows for a clearer cost-benefit assessment per patient. Viz AAA operates on a less transparent subscription model with no public pricing tiers, making it harder for potential customers to evaluate its value proposition upfront.

Enterprise Readiness

Viz AAA

While both are FDA-cleared, HIPAA compliant, and cloud-based with integration capabilities, Viz AAA is part of the broader Viz AORTIC Module and the Viz.ai platform, which is deployed in over 2,000 hospitals across the U.S. and Europe. This indicates a more established and scalable enterprise footprint for comprehensive aortic pathology solutions and broader hospital system integration.

Innovation

Cleerly LABS

Cleerly LABS demonstrates greater innovation by moving beyond simple stenosis detection to offer comprehensive quantification and characterization of coronary plaque (volume, type) and the ability to track disease progression over time. This enables a more personalized and proactive approach to heart disease management, aiming to prevent heart attacks.

Support & Docs

Viz AAA

Viz AAA offers more extensive and immediate support, including 24/7/365 urgent phone support, email, and in-app assistance, complemented by a dedicated customer success team with specialists for workflow optimization. Cleerly LABS provides standard business-hour client support via a form and general contact information, which is less comprehensive for critical healthcare environments.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS Viz AAA
Primary Function/Target Condition Comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis. Detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans.
AI-powered Analysis Focus CCTA image analysis for comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, and ischemia detection (with Cleerly ISCHEMIA module). Automatic detection of suspected AAA from CTA scans and automated triage and prioritization of cases.
Key Output/Benefit Comprehensive coronary plaque assessment, stenosis detection, 3D visualization, personalized heart disease risk assessment, tracking disease progression. Automated detection of suspected AAA, automated triage and prioritization, real-time alerts to care teams, mobile access to imaging and patient information.
Integration Capabilities Integration with PACS, RIS, EHR via Cleerly Proxy. Integration into existing hospital workflows, HIPAA-compliant communication platform for multidisciplinary teams.
Specialties Served Cardiology, Radiology. Emergency Medicine, Radiology, Vascular Surgery.

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and Viz AAA.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is designed for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis in coronary arteries, aiding in personalized heart disease management. Viz AAA is an AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans.
Cleerly LABS is priced per analysis, with a retail price of $1500, currently offered at a discounted rate of $750 for the analysis, separate from the CCTA scan cost. Some insurance coverage may be available, but it is often an out-of-pocket expense, totaling around $1000-$1500 including the scan. Viz AAA operates on a subscription model, with an annual fee determined by the number of algorithms used and the size of the population served, and no public pricing tiers are available.
Cleerly LABS provides comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, 3D visualization of coronary arteries, and can detect ischemia with its ISCHEMIA module. Viz AAA focuses on automatic detection and triage of suspected AAA from CTA scans, offering automated prioritization of cases, real-time alerts to care teams, and a HIPAA-compliant communication platform.
Cleerly LABS is primarily used by Cardiology and Radiology specialists for heart disease management. Viz AAA is designed to support Emergency Medicine, Radiology, and Vascular Surgery, particularly for rapid diagnosis and care coordination of AAA.
Cleerly LABS utilizes an on-site Cleerly Proxy for data transfer and integration with PACS, RIS, and EHR systems. Viz AAA is designed for integration into existing hospital workflows, providing real-time alerts and a HIPAA-compliant communication platform for multidisciplinary teams, with mobile access to imaging and patient information.
Yes, Cleerly LABS offers the ability to track disease progression over time, including changes in plaque buildup. Viz AAA is part of the Viz AORTIC Module, which is designed for comprehensive aortic pathology solutions, implying capabilities for managing and potentially tracking aortic conditions.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.